Accreditation/Credit Designation

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is supported by an educational grant from Kadmon Corporation.

What You Need To Know On cGVHD for 2021

Release Date: January 26, 2021
Expiration Date: January 26, 2022

Activity Overview

Burst CME™: What You Need To Know on cGVHD for 2021 is a brief online activity featuring written text and expert audio commentary regarding the diagnostic and treatment outlook of chronic graft-versus-host disease (cGVHD) in 2021. During this online program, Iskra Pusic, MD, an associate professor of oncology at the Washington University School of Medicine in St Louis, Missouri, answers important questions and offers her perspectives on emerging approaches to managing cGVHD.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Kadmon Corporation.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

These activities are intended for hematologists and medical oncologists interested in the latest advances in the treatment of patients with cGVHD. Fellows, researchers, nurses, nurse practitioners, physician assistants, and other health care professionals interested in the treatment of patients with cGVHD are also invited to attend.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Review current criteria for the diagnosis, staging, and grading of cGVHD
  • Discuss emerging management strategies for cGVHD

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.


Iskra Pusic, MD
Iskra Pusic, MD
Associate Professor
Bone Marrow Transplantation & Leukemia
Oncology Division
Washington University School of Medicine in St Louis
St Louis, MO

Disclosures: Consultant: Incyte Corporation, Kadmon Corporation, Syndax Pharmaceuticals.

The staff of Physicians' Education Resource®, LLC (PER®) have no relevant financial relationships with commercial interests to disclose.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By